Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy

Neurology

Volumn 46, Issue 4, 1996, Pages 1156-1157

  Anouti, A ^a   Schmidt, K ^a   Lyons, K E ^a   Hubble, J P ^a   Schellenberg, G ^b   Golbe, L I ^c   Lang, A E ^d   Galvez Jimenez, N ^d   Hershey, L ^e   Koller, W C ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MALE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; STATISTICAL ANALYSIS;

EID: 9244249794     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.4.1156     Document Type: Article

References (17)

1. Strittmatter WJ, Saunders AM, Schmechal D, et al. Apolipoprotein E: high-affinity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90:1977-1981.
2. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein ∈4 gene dose affects the risk of Alzheimer disease in late onset families. Science 1993; 261:921-923.
3. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele ∈4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44:1950-1951.
4. Koller WC, Glatt SL, Hubble JP, et al. Apo E genotypes in Parkinson's disease with and without dementia. Ann Neurol 1995; 37:242-245.
5. Muramatsu T, Higuehi S, Arai H, et al. Apolipoprotein E ∈4 allele distribution in alcoholic dementia and in Alzheimer's disease in Japan. Ann Neurol 1994; 36:797-799.
6. Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford Press, 1992.
7. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994; 125:163-171.
8. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31:545-548.
9. Han S-H, Halette C, Saunders AM. Apolipoprotein E is present in hippocampal neurons in Alzheimer's disease and in age-matched controls. Exp Neurol 1944; 128:13-26.
10. Duvoisin RC. Clinical diagnosis. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:15-33.
11. Litvan I, Grafman J, Gomez C, Chase TN. Memory impairment in patients with progressive supranuclear palsy. Arch Neurol 1989; 46:765-767.
12. Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991; 41:634-643.
13. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015-2019.
14. Cardoso F, Jankovic J. Progressive supranuclear palsy. In, Calne DB, ed. Neurodegenerative disease. Philadelphia: WB Saunders, 1994:769-786.
15. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E ∈4 allele in Alzheimer's disease and vascular dementia. Dementia 1994; 5:240-242.
16. Pirtilla T, Lehtimaki T, Nikkari T, et al. Apolipoprotein E ∈4 allele and risk of dementia. JAMA 1995; 273:375-376.
17. Waring SC, O'Bryan PC, Kurland LT, et al. Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis-parkinsonian-dementia complex. Lancet 1994; 343:611.